| Landscape of somatic mutations in 560 breast cancer whole-genome sequences S Nik-Zainal, H Davies, J Staaf, M Ramakrishna, D Glodzik, X Zou, ... Nature 534 (7605), 47-54, 2016 | 2160 | 2016 |
| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 1653* | 2020 |
| miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors E Enerly, I Steinfeld, K Kleivi, SK Leivonen, MR Aure, HG Russnes, ... PloS one 6 (2), e16915, 2011 | 341 | 2011 |
| Breast cancer quantitative proteome and proteogenomic landscape HJ Johansson, F Socciarelli, NM Vacanti, MH Haugen, Y Zhu, I Siavelis, ... Nature communications 10 (1), 1600, 2019 | 170 | 2019 |
| Targeted exploration and analysis of large cross-platform human transcriptomic compendia Q Zhu, AK Wong, A Krishnan, MR Aure, A Tadych, R Zhang, DC Corney, ... Nature methods 12 (3), 211-214, 2015 | 143 | 2015 |
| Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors A Tahiri, SK Leivonen, T Lüders, I Steinfeld, M Ragle Aure, J Geisler, ... Carcinogenesis 35 (1), 76-85, 2014 | 141 | 2014 |
| Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c MK Nygren, C Tekle, VA Ingebrigtsen, R Mäkelä, M Krohn, MR Aure, ... British journal of cancer 110 (8), 2072-2080, 2014 | 133 | 2014 |
| Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors MR Aure, SK Leivonen, T Fleischer, Q Zhu, J Overgaard, J Alsner, ... Genome biology 14, 1-20, 2013 | 110 | 2013 |
| Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome MR Aure, V Vitelli, S Jernström, S Kumar, M Krohn, EU Due, TH Haukaas, ... Breast Cancer Research 19, 1-18, 2017 | 102 | 2017 |
| Molecular features of subtype-specific progression from ductal carcinoma in situ to invasive breast cancer R Lesurf, MR Aure, HH Mørk, V Vitelli, T Sauer, J Geisler, S Hofvind, ... Cell reports 16 (4), 1166-1179, 2016 | 96 | 2016 |
| Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins S Myhre, OC Lingjærde, BT Hennessy, MR Aure, MS Carey, J Alsner, ... Molecular oncology 7 (3), 704-718, 2013 | 84 | 2013 |
| LIMT is a novel metastasis inhibiting lnc RNA suppressed by EGF and downregulated in aggressive breast cancer A Sas‐Chen, MR Aure, L Leibovich, S Carvalho, Y Enuka, C Körner, ... EMBO molecular medicine 8 (9), 1052-1064, 2016 | 83 | 2016 |
| Metabolic clusters of breast cancer in relation to gene-and protein expression subtypes TH Haukaas, LR Euceda, GF Giskeødegård, S Lamichhane, M Krohn, ... Cancer & metabolism 4, 1-14, 2016 | 73 | 2016 |
| Identifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression data MR Aure, I Steinfeld, LO Baumbusch, K Liestøl, D Lipson, S Nyberg, ... PloS one 8 (1), e53014, 2013 | 68 | 2013 |
| miRNA551b-3p activates an oncostatin signaling module for the progression of triple-negative breast cancer D Parashar, A Geethadevi, MR Aure, J Mishra, J George, C Chen, ... Cell reports 29 (13), 4389-4406. e10, 2019 | 67 | 2019 |
| Subtype‐specific micro‐RNA expression signatures in breast cancer progression VD Haakensen, V Nygaard, L Greger, MR Aure, B Fromm, IRK Bukholm, ... International journal of cancer 139 (5), 1117-1128, 2016 | 67 | 2016 |
| Copy number gain of hsa-miR-569 at 3q26. 2 leads to loss of TP53INP1 and aggressiveness of epithelial cancers P Chaluvally-Raghavan, F Zhang, S Pradeep, MP Hamilton, X Zhao, ... Cancer Cell 26 (6), 863-879, 2014 | 53 | 2014 |
| Integrated analysis reveals microRNA networks coordinately expressed with key proteins in breast cancer MR Aure, S Jernström, M Krohn, HKM Vollan, EU Due, E Rødland, ... Genome medicine 7, 1-17, 2015 | 45 | 2015 |
| miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer EM Lindholm, M Ragle Aure, MH Haugen, K Kleivi Sahlberg, ... Molecular oncology 13 (10), 2278-2296, 2019 | 35 | 2019 |
| Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer MR Aure, T Fleischer, S Bjørklund, J Ankill, JA Castro-Mondragon, ... Genome medicine 13 (1), 72, 2021 | 34 | 2021 |
